April 2021 – Deep Tech Leaders supports DNAe with the appointment of Richard Hammond as Vice President, Technology.
The Deep Tech Leaders team is delighted to have recently supported DNAe in the appointment of Richard Hammond as their new Vice President of Technology.
Richard has enjoyed a long career developing innovative, first-of-their-kind diagnostics. For 6-years, he worked at Alere, where he delivered from research a next generation isothermal diagnostic, the world’s first nucleic acid-based diagnostic test to achieve CLIA waiver. Most recently, Richard has been Technology Director and Head of Bioinnovation at Cambridge Consultants.
The realisation of clinically-applicable, next-generation sequencing solutions represents one of today’s greatest technology challenges. The potential benefits are enormous, ushering in diagnosis that is faster, more accurate, and far more comprehensive than traditional methods. But the scale of the challenge is significant.
DNAe is a pioneer in this vital field. For more than 10-years, the company has applied its expertise in diagnostic and semiconductor technologies to bring innovative, life-saving benefits to patients. DNAe is taking DNA sequencing from specialised genome centres into hospitals, the clinic and the point of care.
Today, this award-winning company is a highly specialised team of professionals based in London and Carlsbad, California. The company is developing its DNA sequencing platform for the rapid diagnosis of infectious diseases, antibiotic resistance and cancer.
For more information on DNAe, please refer to their website at dnae.com.
Deep Tech Leaders is an executive search firm recruiting boards and leadership teams for Deep Tech start-ups & scale-ups serving the Industrial, Life Science and Computing domains. Headquartered in London, we partner with mission-oriented innovators and investors to help bring about a cleaner, healthier, more intelligent world.